Biomaterial Database

Management of recurrent hepatitis C in orthotopic liver transplant recipients. 2013

Geeta S Karnik, and Kirti Shetty

Department of Infectious Diseases, Georgetown University Hospital, Washington, DC 20007, USA. Geeta.S.Karnik@gunet.georgetown.edu

End-stage liver disease and hepatocellular carcinoma from chronic hepatitis C are the most common indications for orthotopic liver transplantation and the incidence of both are projected to increase over the next decade. Recurrent hepatitis C virus infection of the allograft is associated with an accelerated progression to cirrhosis, graft loss, and death. This article presents an overview of the natural history of hepatitis C virus recurrence in liver transplant recipients and guidance on optimal management strategies.

UI	MeSH Term	Description	Entries
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.	Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014180	Transplantation	Transference of a tissue or organ from either an alive or deceased donor, within an individual, between individuals of the same species, or between individuals of different species.	Transplantations
D016031	Liver Transplantation	The transference of a part of or an entire liver from one human or animal to another.	Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D055502	Secondary Prevention	The prevention of recurrences or exacerbations of a disease or complications of its therapy.	Disease Prevention, Secondary,Early Therapy,Relapse Prevention,Secondary Disease Prevention,Disease Preventions, Secondary,Early Therapies,Prevention, Relapse,Prevention, Secondary,Prevention, Secondary Disease,Preventions, Relapse,Preventions, Secondary,Preventions, Secondary Disease,Relapse Preventions,Secondary Disease Preventions,Secondary Preventions,Therapies, Early,Therapy, Early
D019698	Hepatitis C, Chronic	INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.	Chronic Hepatitis C

Related Publications

Geeta S Karnik, and Kirti Shetty

Management of recurrent hepatitis C in liver transplant recipients.

March 2006, Infectious disease clinics of North America,

Geeta S Karnik, and Kirti Shetty

Management of liver transplant recipients with recurrent hepatitis C.

June 2009, Current opinion in organ transplantation,

Geeta S Karnik, and Kirti Shetty

The Reliability of Fibro-test in Staging Orthotopic Liver Transplant Recipients with Recurrent Hepatitis C.

March 2020, Journal of clinical and translational hepatology,

Geeta S Karnik, and Kirti Shetty

Treatment of recurrent hepatitis C in liver transplant recipients.

October 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,

Geeta S Karnik, and Kirti Shetty

Management of hepatitis C in liver transplant recipients.

March 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,

Geeta S Karnik, and Kirti Shetty

Recurrent hepatocellular carcinoma in liver transplant recipients with hepatitis C.

June 2012, Journal of gastrointestinal cancer,

Geeta S Karnik, and Kirti Shetty

Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis.

February 1996, Transplantation,

Geeta S Karnik, and Kirti Shetty

The challenge of recurrent hepatitis C virus in liver transplant recipients.

October 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie,

Geeta S Karnik, and Kirti Shetty

Practical management of liver transplant recipients for hepatitis C.

August 2003, Minerva chirurgica,